A systematic review of the treatment of depression with antidepressant drugs in patients who also have a physical illness

被引:61
作者
Gill, D [1 ]
Hatcher, S
机构
[1] Whipps Cross Hosp & Chest Clin, Dept Liaison Psychiat, London E11 1NR, England
[2] Univ Auckland, Dept Psychiat, Auckland 1, New Zealand
基金
英国医学研究理事会;
关键词
depression; physical illness; systematic review; randomised controlled trial; therapy; antidepressant medication;
D O I
10.1016/S0022-3999(99)00020-3
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
determine whether antidepressants are clinically effective and acceptable for the treatment of depression in people who also have a physical illness. The method used was a systematic review of all randomised controlled trials (found by computer and hand searches) comparing any antidepressant drug with placebo or no treatment, in depressed adults with a specified,physical disorder. The main outcome measures are numbers of individuals who recover/improve at the end of the trial and, as a proxy for treatment acceptability, numbers who complete treatment. 18 studies were included, covering 838 pa patients with a range of physical diseases. 6 studies used SSRIs, 3 atypical antidepressants, and the remainder tricyclics. Patients treated with antidepressants were significantly more likely to improve than those given placebo: about 4 patients would need to be treated with antidepressants to produce one recovery from depression which would not have occurred had they been given placebo (NNT 4.2, 95% CI 3.2-6.4). Most antidepressants (tricyclics and SSRIs together, 15 trials) produced a small but significant increase in dropout (OR 1.66, 95% CI 1.14-2.40. NNH 9.8, 95% CI 5.4-42.9). The "atypical" antidepressant mianserin produced significantly less dropout than placebo. Trends towards tricyclics being more effective than SSRIs, but also more likely to produce dropout were noted. The review provides evidence that antidepressants, significantly more frequently than either placebo or no treatment, cause improvement in depression in patients with a wide range of physical diseases. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:131 / 143
页数:13
相关论文
共 33 条
[1]   EFFECTIVE TREATMENT OF POSTSTROKE DEPRESSION WITH THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR CITALOPRAM [J].
ANDERSEN, G ;
VESTERGAARD, K ;
LAURITZEN, L .
STROKE, 1994, 25 (06) :1099-1104
[2]   Fluoxetine in depressed patients on dialysis [J].
Blumenfield, M ;
Levy, NB ;
Spinowitz, B ;
Charytan, C ;
Beasley, CM ;
Dubey, AK ;
Solomon, RJ ;
Todd, R ;
Goodman, A ;
Bergstrom, RF .
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 1997, 27 (01) :71-80
[3]   IMPROVEMENT IN MOOD, PHYSICAL SYMPTOMS, AND FUNCTION WITH NORTRIPTYLINE FOR DEPRESSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
BORSON, S ;
MCDONALD, GJ ;
GAYLE, T ;
DEFFEBACH, MPHM ;
LAKSHMINARAYAN, S ;
VANTUINEN, C .
PSYCHOSOMATICS, 1992, 33 (02) :190-201
[4]  
*BRIT MED ASS ROYA, 1996, BRIT NAT FORM
[5]  
*COCHR LIB, 1998, COCHR HDB
[6]   EFFICACY AND SAFETY OF MIANSERIN IN THE TREATMENT OF DEPRESSION OF WOMEN WITH CANCER [J].
COSTA, D ;
MOGOS, I ;
TOMA, T .
ACTA PSYCHIATRICA SCANDINAVICA, 1985, 72 :85-92
[7]  
Elliott AJ, 1998, AM J PSYCHIAT, V155, P367
[8]  
Evans M, 1997, INT J GERIATR PSYCH, V12, P817, DOI 10.1002/(SICI)1099-1166(199708)12:8<817::AID-GPS645>3.0.CO
[9]  
2-4
[10]   DEPRESSION AND 18-MONTH PROGNOSIS AFTER MYOCARDIAL-INFARCTION [J].
FRASURESMITH, N ;
LESPERANCE, F ;
TALAJIC, M .
CIRCULATION, 1995, 91 (04) :999-1005